Patents Assigned to Adynxx Sub, Inc.
  • Oligonucleotide decoys for the treatment of pain
    Patent number: 10683502
    Abstract: Provided are therapeutic agents such as double-stranded nucleic acids, termed oligonucleotide decoys, pharmaceutical compositions comprising the same, and related methods of modulating nociceptive signaling, for instance, to prevent and/or treat pain.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: June 16, 2020
    Assignee: ADYNXX SUB, INC.
    Inventors: Julien Mamet, Rick Orr, Donald C. Manning, Scott Harris, William Martin
  • Formulations for the delivery of active ingredients
    Patent number: 10434178
    Abstract: This invention relates generally to in vivo delivery of active ingredient formulations. More particularly, this invention relates to formulations of active ingredients that further comprise an agent, methods of making such formulations, and methods of using the same.
    Type: Grant
    Filed: April 5, 2017
    Date of Patent: October 8, 2019
    Assignee: Adynxx Sub, Inc.
    Inventors: Julien Mamet, Scott Harris, George Miljanich, Rick Orr, William K. Schmidt, Tony Yaksh, David C. Yeomans